WORLD PEPTIDEFOUNDATION

Peptide directory

Find a peptide

Public profiles inside a larger governed registry

Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.

Browse the Master RegistryExplore research atlasesFind studies worldwide

The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.

Published profiles

Search profiles and sources

Compare peptides side by side →
Refine by category
Category

405 peptide records

  • Long-acting GLP-1 receptor agonist conjugate

    Efpeglenatide

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for Efpeglenatide →

  • Mitochondria-targeting peptide

    Elamipretide

    Synthetic peptide

    Evidence published; synthesis pending

    Mitochondria-targeting aromatic-cationic tetrapeptide that interacts with cardiolipin; evidence is separated by disease and endpoint.

    Evidence and record details

    Evidence integrity map

    Human 0Preclinical 0Durable IDs 4Open signals 2
    Publication state
    Published profile
    Verified source records
    26 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for Elamipretide

  • Bioactive tachykinin peptide

    Eledoisin

    Published sources available; full evidence profile in development.

    4 published source records. Source publication does not imply scientific appraisal.

    Open sources for Eledoisin →

  • Amylin receptor agonist peptide

    Eloralintide

    Published sources available; full evidence profile in development.

    4 published source records. Source publication does not imply scientific appraisal.

    Open sources for Eloralintide →

  • Synthetic peptide

    Emideltide

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Emideltide →

  • HIV fusion inhibitor peptide

    Enfuvirtide

    Published sources available; full evidence profile in development.

    5 published source records. Source publication does not imply scientific appraisal.

    Open sources for Enfuvirtide →

  • Synthetic tetrapeptide bioregulator

    Epitalon

    Emerging

    Epitalon (also transliterated Epithalon) is the tetrapeptide Ala-Glu-Asp-Gly associated with Russian peptide-bioregulator research. Proposed effects include modulation of gene expression, circadian biology, oxidative stress, and telomerase-related pathways, but mechanisms and clinical relevance remain uncertain.

    Evidence and record details

    Evidence integrity map

    Human 1Preclinical 14Durable IDs 25Open signals 3
    Publication state
    Published profile
    Verified source records
    25 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    22 open research questions
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for Epitalon

  • Peptide extract/reference entity

    Epithalamin

    Published sources available; full evidence profile in development.

    2 published source records. Source publication does not imply scientific appraisal.

    Open sources for Epithalamin →
How the public directory relates to the 500-record Master Registry

master registry transparency

500 master records, with governance status shown explicitly

WPF-MASTER-REGISTRY-TRANSPARENCY-1.0
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators

The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.

Explore the full Master Registry →
What the profile status labels mean

Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.

Recently updated public records

When each public profile record was last changed — not clinical or scientific activity.

Peptide Directory — World Peptide Foundation